CODX - CIK 0001692415
The table below shows Co-Diagnostics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.23M | $11.44M | $11.12M | $1.90M | $10.80M | $13.86M |
| Short-term investments | - | $26.81M | $2.25M | $19.58M | $26.86M | $31.02M |
| Receivables | $82.34K | $55.91K | $210.97K | $136.39K | $178.24K | $551.50K |
| Inventory | $846.12K | $1.09M | $1.08M | $1.08M | $1.27M | $1.46M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $9.78M |
| $14.05M |
| $15.31M |
| $23.83M |
| $40.10M |
| $48.22M |
| Property, plant & equipment | $2.16M | $2.49M | $2.67M | $2.59M | $2.98M | $3.05M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $21.50M | $44.74M | $46.47M | $55.15M | $72.38M | $80.70M |
| Accounts payable | $2.02M | $1.46M | $1.64M | $2.71M | $2.18M | $1.86M |
| Total current liabilities | $4.28M | $3.69M | $3.71M | $5.38M | $5.80M | $5.31M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $5.46M | $4.91M | $5.33M | $7.23M | $8.60M | $8.30M |
| Retained earnings | -$89.51M | -$54.19M | -$48.30M | -$40.57M | -$22.01M | -$12.31M |
| Total equity | $16.04M | $39.83M | $41.14M | $47.92M | $63.78M | $72.40M |